What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Gene
His primary areas of study are Internal medicine, Endocrinology, Cardiology, Cholesterol and Lipoprotein.
The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus and Placebo.
Christie M. Ballantyne interconnects Gastroenterology and Hazard ratio in the investigation of issues within Endocrinology.
His Cholesterol study incorporates themes from Statin, Simvastatin and National Cholesterol Education Program.
The study incorporates disciplines such as Fluvastatin and Coronary atherosclerosis in addition to Lipoprotein.
His work in Myocardial infarction addresses subjects such as Disease, which are connected to disciplines such as Inflammation.
His most cited work include:
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (3050 citations)
- Biological, clinical and population relevance of 95 loci for blood lipids (2804 citations)
- From Vulnerable Plaque to Vulnerable Patient A Call for New Definitions and Risk Assessment Strategies: Part I (2483 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Cardiology, Endocrinology, Cholesterol and Diabetes mellitus.
His works in Disease, Heart failure, Lipoprotein, Hazard ratio and Statin are all subjects of inquiry into Internal medicine.
His studies in Hazard ratio integrate themes in fields like Prospective cohort study and Proportional hazards model.
His Cardiology research incorporates elements of Stroke and Confidence interval.
Christie M. Ballantyne has researched Cholesterol in several fields, including Gastroenterology and Simvastatin.
While the research belongs to areas of Ezetimibe, he spends his time largely on the problem of Atorvastatin, intersecting his research to questions surrounding Ezetimibe/simvastatin and Rosuvastatin.
He most often published in these fields:
- Internal medicine (83.05%)
- Cardiology (38.00%)
- Endocrinology (31.39%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (83.05%)
- Cardiology (38.00%)
- Disease (16.38%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Cardiology, Disease, Heart failure and Atherosclerosis Risk in Communities.
The study incorporates disciplines such as Diabetes mellitus and Endocrinology in addition to Internal medicine.
Christie M. Ballantyne works mostly in the field of Cardiology, limiting it down to topics relating to PCSK9 and, in certain cases, Evolocumab, as a part of the same area of interest.
His work in Heart failure covers topics such as Stroke which are related to areas like Myocardial infarction.
As part of the same scientific family, he usually focuses on Hazard ratio, concentrating on Prospective cohort study and intersecting with Cohort study.
His Atherosclerotic cardiovascular disease research incorporates themes from Dyslipidemia, Statin, Statin therapy, Cholesterol and Low density lipoprotein cholesterol.
Between 2017 and 2021, his most popular works were:
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia (958 citations)
- Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: Analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) (170 citations)
- Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel. (131 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
Internal medicine, Cardiology, Hazard ratio, Disease and Heart failure are his primary areas of study.
His work deals with themes such as Diabetes mellitus and Placebo, which intersect with Internal medicine.
His studies in Cardiology integrate themes in fields like Odds ratio, Epidemiology, Risk assessment and C-reactive protein.
His Hazard ratio research includes themes of Body mass index, Prospective cohort study, Proportional hazards model and Lipoprotein-associated phospholipase A2.
His research on Heart failure also deals with topics like
- Subclinical infection together with Obesity,
- Stroke together with High sensitivity troponin.
His Cholesterol study necessitates a more in-depth grasp of Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
